XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
                 
Research and development  $31,016   $57,786   $66,989   $112,866 
General and administrative   34,189    44,479    69,218    88,705 
                     
Total  $65,205   $102,265   $136,207   $201,571 
Schedule of Key Assumption of Fair Value of Stock Options Granted

For options granted during the six months ended June 30, 2025 and 2024, the Company calculated the fair value of each option grant on the respective dates of grant using the following weighted average assumptions:

 

   2025   2024 
Expected term   5.73 years    5.76 years 
Risk-free interest rate   4.30%   4.32%
Expected dividend yield        
Expected volatility   94.19%   97.78%
Schedule of Stock Option Activity

A summary of stock option activity is as follows:

 

   Outstanding stock options 
   Number of shares   Weighted average exercise price 
Balance at December 31, 2023    262,247   $34.21 
Options granted    84,715    4.79 
Options exercised    -    - 
Options forfeited    (10,209)   142.99 
Options cancelled    (1,495)   5.23 
Balance at December 31, 2024    335,258    23.59 
Options granted    25,191    4.28 
Options exercised    -    - 
Options forfeited    (5,541)   85.10 
Options cancelled    -    - 
Balance at June 30, 2025    354,908    21.26 
           
Options exercisable at June 30, 2025   256,738    27.57 
Schedule of Share-based Compensation of Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable:

 

As of June 30, 2025 
Options outstanding   Options exercisable 
Number outstanding   Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value   Number exerciseable   Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value 
                                      
 354,908    6.60   $21.26   $-    256,738    5.59   $27.57   $- 

 

As of June 30, 2024 
Options outstanding   Options exercisable 
Number outstanding   Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value   Number exerciseable   Weighted average remaining contractual life (Years)   Weighted average exercise price   Aggregate intrinsic value 
                                      
 295,517    6.55   $30.36   $230,307    224,887    5.79   $37.54   $77,671 
Summary of Restricted Stock Unit Activity

A summary of restricted stock unit activity is as follows:

 

   Number of Unvested Restricted Stock Units 
     
Balance at December 31, 2024   21,762 
Granted   - 
Vested   (2,416)
Cancelled   - 
Balance at June 30, 2025   19,346 

 

   Number of Unvested Restricted Stock Units 
Balance at December 31, 2023   - 
Granted   21,762 
Vested   - 
Cancelled   - 
Balance at June 30, 2024   21,762